Vaishali Pharma Ltd vs Zenotech Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Vaishali Pharma Ltd is ₹ 7.73 as of 05 May 15:30 . The P/E Ratio of Vaishali Pharma Ltd changed from 32.9 on March 2021 to 209.7 on March 2025 . This represents a CAGR of 44.84% over 5 yearsThe P/E Ratio of Zenotech Laboratories Ltd changed from 13.9 on March 2022 to 56.4 on March 2025 . This represents a CAGR of 41.93% over 4 years The Market Cap of Vaishali Pharma Ltd changed from ₹ 171.9 crore on March 2021 to ₹ 134.85 crore on March 2025 . This represents a CAGR of -4.74% over 5 yearsThe Market Cap of Zenotech Laboratories Ltd changed from ₹ 213.61 crore on March 2021 to ₹ 316.87 crore on March 2025 . This represents a CAGR of 8.21% over 5 years The Revenue of Vaishali Pharma Ltd is ₹ 24.59 crore as of Jun '25 .The Revenue of Zenotech Laboratories Ltd is ₹ 0 crore as of Jun '25 . The EBITDA of Vaishali Pharma Ltd is ₹ 2.21 crore as of Jun '25 .The EBITDA of Zenotech Laboratories Ltd is ₹ 0 crore as of Jun '25 . The Net Profit of Vaishali Pharma Ltd is ₹ 1.28 crore as of Jun '25 .The Net Profit of Zenotech Laboratories Ltd is ₹ 0 crore as of Jun '25 . The Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zenotech Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
M/s.
Vaishali Pharmachem through Business Assignment agreement.
Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

About Zenotech Laboratories Ltd

Zenotech Laboratories Limited was initially established as Sunline Technologies Limited in June, 1989 and changed to the present name w.e.f.
August 9, 2004.
Company is a loan licensing company catering exclusively to Sun Pharmaceutical Industries Limited, Promoter & holding company and they are specialized contract manufacturing services /processing in parenteral depot formulations, ophthalmic, oncology oral & injectables and general injectables.
Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. During financial year 2004-05, the Hon'ble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s.
Zenotech Technologies Limited with effect from November 1st , 2003.

FAQs for the comparison of Vaishali Pharma Ltd and Zenotech Laboratories Ltd

Which company has a larger market capitalization, Vaishali Pharma Ltd or Zenotech Laboratories Ltd?

Market cap of Vaishali Pharma Ltd is 96 Cr while Market cap of Zenotech Laboratories Ltd is 268 Cr

What are the key factors driving the stock performance of Vaishali Pharma Ltd and Zenotech Laboratories Ltd?

The stock performance of Vaishali Pharma Ltd and Zenotech Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Vaishali Pharma Ltd and Zenotech Laboratories Ltd?

As of May 5, 2026, the Vaishali Pharma Ltd stock price is INR ₹7.43. On the other hand, Zenotech Laboratories Ltd stock price is INR ₹44.02.

How do dividend payouts of Vaishali Pharma Ltd and Zenotech Laboratories Ltd compare?

To compare the dividend payouts of Vaishali Pharma Ltd and Zenotech Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.